News - Zhongshan Wanhan Pharmaceuticals Co., Ltd

2024 Zhongshan Cuiheng Island Marathon: Striving for Excellence and Pushing Forward.
WANHAN PHARMACEUTICAL COMPANY: Congratulations on the successful approval of 2% and 5% Minoxidil Topical Solution.
WANHAN PHARMACEUTICAL COMPANY: Hydrobromide Vortioxetine API has been authorized.
WANHAN PHARMACEUTICAL COMPANY: Statement regarding the employment status of our sales staff.
WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium API has successfully upgraded to Class A.